ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Indianapolis, IN, USA:

Incorporating Mind-body Skills with Diabetes Education in Adolescents with Type 1 Diabetes

Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compl...

Active, not recruiting
Type 1 Diabetes
Adolescent Behavior
Behavioral: Diabetes education
Behavioral: Mind-body skills
Indiana University
Indiana University

Indianapolis, Indiana, United States and 1 other location

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Indianapolis, Indiana, United States and 9 other locations

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Indianapolis, Indiana, United States and 56 other locations

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Enrolling
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Indianapolis, Indiana, United States and 5 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Indianapolis, Indiana, United States and 64 other locations

New

randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes...

Begins enrollment in 1 month
Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes
Other: Standard of Care (SC)
Device: An AID System.
Embecta Corp.

Indianapolis, Indiana, United States and 8 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Indianapolis, Indiana, United States and 37 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Enrolling
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Indianapolis, Indiana, United States and 19 other locations

Locations recently updated

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Avon, Indiana, United States and 175 other locations

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes...

Enrolling
Type 1 Diabetes Mellitus with Hypoglycemia
Drug: Placebo
Drug: ZT-01, 22 mg

Phase 2

Zucara Therapeutics

Indianapolis, Indiana, United States and 24 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems